# ClinicalTrials.gov record NCT01550653

> PeptideScanner retained ClinicalTrials.gov record NCT01550653 at 2026-07-30T21:54:46.545Z. Its registry update date was 2014-02-27, and PeptideScanner's reviewed identity mapping was liraglutide.

- Evidence object: `story:clinicaltrials-gov-nct01550653-liraglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2014-02-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01550653-liraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01550653-liraglutide-v1.json
- Content SHA-256: `23b0f6b77ae3cb133f987cfe4498d252009008a7f141df4fcf96ef5f05f41186`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01550653 ([`ctg-observation-nct01550653-2014-02-27-fad07de5b84a`](#source-ctg-observation-nct01550653-2014-02-27-fad07de5b84a))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01550653 at 2026-07-30T21:54:46.545Z. Its registry update date was 2014-02-27, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct01550653-2014-02-27-fad07de5b84a`](#source-ctg-observation-nct01550653-2014-02-27-fad07de5b84a))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01550653 at 2026-07-30T21:54:46.545Z. Its registry update date was 2014-02-27, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct01550653-2014-02-27-fad07de5b84a`](#source-ctg-observation-nct01550653-2014-02-27-fad07de5b84a))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01550653-2014-02-27-fad07de5b84a`](#source-ctg-observation-nct01550653-2014-02-27-fad07de5b84a))

## Sources

<a id="source-ctg-observation-nct01550653-2014-02-27-fad07de5b84a"></a>
- **ClinicalTrials.gov record NCT01550653 · retained source version 2014-02-27:fad07de5b84adafc181135b4dda6da3f9c21a6957f74ab95a3a7e5f15abeaf89** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01550653) (`ctg-observation-nct01550653-2014-02-27-fad07de5b84a`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01550653." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01550653-liraglutide-v1.json SHA-256: 23b0f6b77ae3cb133f987cfe4498d252009008a7f141df4fcf96ef5f05f41186.